a patient-focused transcatheter portfolio of options to treat tricuspid regurgitation - europcr 2022
Published 2 years ago • 1.8K plays • Length 1:33:46Download video MP4
Download video MP3
Similar videos
-
59:59
a new focus on mitral and tricuspid valve disease - europcr 2022
-
6:51
surgical and transcatheter treatment options for tricuspid regurgitation - europcr 2017
-
59:44
edwards' transcatheter trilogy: an exclusive portfolio of 3 options to treat tr - pcr london valves
-
1:22:38
2022: a tipping point in the treatment of mitral regurgitation patients - europcr 2022
-
8:51
transcatheter trilogy part 3: edwards’ portfolio of tricuspid treatment options | presentation
-
3:34
“clear need” for transcatheter options for tricuspid regurgitation - europcr 2022
-
4:42
addressing tricuspid regurgitation with annular reduction: the cardioband tricuspid system
-
11:44
a comprehensive portfolio to treat tricuspid regurgitation - pcr london valves 2022
-
45:08
tricuspid regurgitation: a new prospect in the management of patients - gulfpcr-gim 2022
-
58:52
triclip therapy: here now, here to stay - europcr 2022
-
58:48
advancing solutions for tricuspid regurgitation patients: introducing triclip g4 - europcr 2021
-
32:28
transcatheter options & management of mitral or tricuspid regurgitation | 2021 esc guidelines update
-
5:38
transcatheter trilogy part 1: edwards’ portfolio of tricuspid treatment options | presentation
-
59:29
rhythm management in patients with tricuspid regurgitation - webinar
-
1:04:05
tailoring tricuspid regurgitation patient treatment with the pascal precision system - europcr 2023
-
17:23
the role of imaging in transcatheter treatment for tricuspid valve disease
-
20:30
from tavi to mitral and tricuspid - applying evidence to expand patients' treatment options
-
9:08
why should an interventional cardiologist be interested in functional tricuspid regurgitation?
-
1:02:06
seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies